» Articles » PMID: 28981842

30 Years On: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2017 Oct 6
PMID 28981842
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

At its re-birth 30 years ago, the neurodevelopment hypothesis of schizophrenia focussed on aberrant genes and early neural hazards, but then it grew to include ideas concerning aberrant synaptic pruning in adolescence. The hypothesis had its own stormy development and it endured some difficult teenage years when a resurgence of interest in neurodegeneration threatened its survival. In early adult life, it over-reached itself with some reductionists claiming that schizophrenia was simply a neurodevelopmental disease. However, by age 30, the hypothesis has matured sufficiently to incorporated childhood and adult adversity, urban living and migration, as well as heavy cannabis use, as important risk factors. Thus, it morphed into the developmental risk factor model of psychosis and integrated new evidence concerning dysregulated striatal dopamine as the final step on the pathway linking risk factors to psychotic symptoms.

Citing Articles

A case of post ictal psychosis with suicidal behavior.

Fischl T, Perucca P Epilepsy Behav Rep. 2025; 29:100727.

PMID: 40027337 PMC: 11869959. DOI: 10.1016/j.ebr.2024.100727.


Blood-Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions.

Zhang F, Zhang J, Wang X, Han M, Fei Y, Wang J Int J Mol Sci. 2025; 26(3).

PMID: 39940642 PMC: 11817713. DOI: 10.3390/ijms26030873.


Examining the role of common variants in rare neurodevelopmental conditions.

Huang Q, Wigdor E, Malawsky D, Campbell P, Samocha K, Chundru V Nature. 2024; 636(8042):404-411.

PMID: 39567701 PMC: 11634775. DOI: 10.1038/s41586-024-08217-y.


Impact of early risk factors on schizophrenia risk and age of diagnosis: A Danish population-based register study.

Lemvigh C, Ambrosen K, Ebdrup B, Glenthoj B, Osler M, Fagerlund B Eur Psychiatry. 2024; 67(1):e64.

PMID: 39344850 PMC: 11536204. DOI: 10.1192/j.eurpsy.2024.1774.


Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations.

Clarin J, Bouras N, Gao W Genes (Basel). 2024; 15(9).

PMID: 39336805 PMC: 11431303. DOI: 10.3390/genes15091214.


References
1.
Stefanis N, Frangou S, Yakeley J, Sharma T, OConnell P, Morgan K . Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol Psychiatry. 1999; 46(5):697-702. DOI: 10.1016/s0006-3223(99)00089-x. View

2.
Lieberman J . Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999; 46(6):729-39. DOI: 10.1016/s0006-3223(99)00147-x. View

3.
Murray R, Fearon P . The developmental 'risk factor' model of schizophrenia. J Psychiatr Res. 2000; 33(6):497-9. DOI: 10.1016/s0022-3956(99)00032-1. View

4.
Poulton R, Caspi A, Moffitt T, Cannon M, Murray R, Harrington H . Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry. 2000; 57(11):1053-8. DOI: 10.1001/archpsyc.57.11.1053. View

5.
Garety P, Kuipers E, Fowler D, Freeman D, Bebbington P . A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001; 31(2):189-95. DOI: 10.1017/s0033291701003312. View